Login

Stéphane Poupinel de Valencé - CEO, New Mauritius Hotels Ltd.| 00:10:00

Share On Facebook Share On Twitter

Discussion about New Mauritius Hotels Ltd. growth and improvement

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Claudio Erba, AI and platform expert and visionary Founder & CEO of Docebo, elucidates the synergy achieved through integration.|Claudio is the founder and CEO of Docebo
00:10:00
Templeton Global Balanced Fund: A Strategic Approach to Diversified Investing | Jane Doe, Portfolio Manager, Templeton Global Balanced Fund, Franklin Templeton Investments
00:10:00
Group CEO of Córas Iompair Éireann (CIE), Bruce Heppenstall, and Plant Director of Drax Group plc, David Johnson, discuss collaborative initiatives in energy and security.
00:10:00
Forte Minerals CEO Patrick Elliott Discusses Copper and Gold Focus in Peru
00:10:00
Weijian Shan on Asia Investments and the Impact of US-China Relations | Weijian Shan, CEO, PAG.
00:00:00
aims to be an innovative drug discovery and development company - Michael A. Martino, Chief Executive Officer, Ampio Pharmaceuticals Inc
00:10:00
Charting the Course: Building a Bellwether Energy Transition Shipping Company | Gerasimos (Jerry) Kalogiratos - Director and CEO of Capital Product Partners L.P.
00:10:00
Dataminr Founder and CEO Ted Bailey discusses the launch of the innovative ReGenAI platform, with AAR CORP. company overview gaining notable attention.|John M. Holmes is Chairman, President and CEO of AAR CORP.
00:10:00
Time to Re-enter the Bond Market with ETFs? | BlackRock Bottom Line
00:10:00
Nothing can stop you if know what is the right path|Zavain Dar,Partner, Lux Capital
00:10:00
Boosting Employee Engagement: Key to Organizational Success
00:10:00
Global venture capital firm focused on multi stage, sector-focused investments|Jenny Lee,Managing Partner,GGV Capital

© 2017 - Neuhu+